U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 19:11:23 GMT 2025
Edited
by admin
on Wed Apr 02 19:11:23 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMANIZED RABBIT
Sequence Type COMPLETE
Record UNII
JL575J4HUJ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
QX-005N
Preferred Name English
Oturkibart
INN  
Official Name English
Immunoglobulin G4 [225-proline], anti-(human interleukin 4 receptor ?) (human-Oryctolagus cuniculus monoclonal QX005N ?4-chain), disulfide with human-Oryctolagus cuniculus monoclonal QX005N ?-chain, dimer
Common Name English
immunoglobulin G4-kappa, anti-[Homo sapiens IL4R (interleukin 4 receptor, IL4RA, IL-4RA, interleukin 13 receptor, CD124)], humanized monoclonal antibody (oturkibart)
Common Name English
H-gamma4 heavy chain humanized (1-444) [VH (Homo sapiens IGHV3-66*01 (83.5%) -(IGHD) -IGHJ2*01 (85.7%) R120>Q (109), CDR-IMGT [8.7.11] (26-33.51-57.96-106)) (1-117) -Homo sapiens IGHG4*01, nG4m(a) CH2 L92, 12-G4v5 h P10 (CH1 (118-215), hinge 1-12 S10>P (
Common Name English
oturkibart [INN]
Common Name English
QX005N
Code English
Code System Code Type Description
INN
13526
Created by admin on Wed Apr 02 19:11:23 GMT 2025 , Edited by admin on Wed Apr 02 19:11:23 GMT 2025
PRIMARY
CAS
2956767-43-2
Created by admin on Wed Apr 02 19:11:23 GMT 2025 , Edited by admin on Wed Apr 02 19:11:23 GMT 2025
PRIMARY
FDA UNII
JL575J4HUJ
Created by admin on Wed Apr 02 19:11:23 GMT 2025 , Edited by admin on Wed Apr 02 19:11:23 GMT 2025
PRIMARY
From To
1_22 1_95
2_22 2_95
2_131 4_217
2_144 2_200
2_258 2_318
1_131 3_217
2_364 2_422
3_23 3_90
3_137 3_197
4_23 4_90
4_137 4_197
1_144 1_200
1_223 2_223
1_226 2_226
1_258 1_318
1_364 1_422
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_294
N 2_294
Related Record Type Details
TARGET->LIGAND
Related Record Type Details
ACTIVE MOIETY
Interleukin 4 receptor antagonists

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID REMOVAL [1_444] [2_444] C-TERMINUS K LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL